Seizing on Opioid Crisis, a Drug Maker Lobbies Hard for Its Product

by | Jun 11, 2017 | Alkermes, Bad Credit Loans, Bank Lending, Buprenorphine (Drug), Business Lending, Business Loans, Capital, Economics, Finance, Lobbying and Lobbyists, Methadone, Non-Bank Loans, Price, Thomas E (1954- ), Prisons and Prisoners, United States Politics and Government, Vivitrol, Working Capital

By ABBY GOODNOUGH and KATE ZERNIKE June 11, 2017 The ads have been popping up on billboards, buses, subways and in glossy magazines, with portraits of attractive men and women and a simple question in bold letters: What is Vivitrol? Five years ago,...

Drug Lobbyists’ Battle Cry Over Prices: Blame the Others

by | May 29, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Campaign Finance, Capital, Drugs (Pharmaceuticals), Economics, Finance, Law and Legislation, Lobbying and Lobbyists, Non-Bank Loans, United States Politics and Government, Working Capital

By ERIC LIPTON and KATIE THOMAS May 29, 2017 WASHINGTON — Hundreds of independent pharmacists swarmed the House and Senate office buildings one recent afternoon, climbing the marble staircases as they rushed from one appointment to the next,...

White House Moves to Block Ethics Inquiry Into Ex-Lobbyists on Payroll

by | May 22, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Conflicts of Interest, Economics, Ethics and Official Misconduct, Finance, Lobbying and Lobbyists, Non-Bank Loans, Office of Government Ethics, Shaub, Walter M Jr, Trump, Donald J, United States Politics and Government, Working Capital

By ERIC LIPTON May 22, 2017 The Trump administration, in a significant escalation of its clash with the government’s top ethics watchdog, has moved to block an effort to disclose the names of former lobbyists who have been granted waivers to work in...